Weight Loss, The CABANA Trial, and the Future of Atrial Fibrillation

Oussama Wazni, MD
Save to PDF CardiologyClinical TrialsExpert Opinion By

Oussama Wazni, MD, is a Staff Physician in the Cleveland Clinic Section of Cardiac Electrophysiology and Pacing. He is the Director of the Outpatient Electrophysiology Department and Co-Director of the Ventricular Arrhythmia Center. He is board-certified in internal medicine, cardiology and cardiac electrophysiology. He specializes in electrophysiology with special interest in atrial fibrillation and ventricular tachycardia ablation.

In this video he addresses the implications of weight loss, bariatric surgery, and the ongoing CABANA trial on the future of treatment of refractory atrial fibrillation.

 


© 2020 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information